PTC Therapeutics (PTCT) Gains as Sarepta's Eteplirsen Approved
Go back to PTC Therapeutics (PTCT) Gains as Sarepta's Eteplirsen ApprovedPTC THERAPEUTICS (NASDAQ: PTCT) | Delayed: 29.09 -0.35 (1.19%) | |||||
---|---|---|---|---|---|---|
Previous Close | $29.44 | 52 Week High | $35.40 | |||
Open | $29.48 | 52 Week Low | $4.03 | |||
Day High | $29.83 | P/E | 3.09 | |||
Day Low | $29.00 | EPS | $9.40 | |||
Volume | 1,083,977 |